Smoking Cessation Support for Sexual and Gender Minorities
This study is testing a program called "Empowering Cessation for the ACS South" to help people quit smoking. All participants will receive a free smoking cessation app from the National Cancer Institute (NCI) and 12 weeks of mailed over-the-counter Nicotine Replacement Therapy (NRT), such as patches, gum, or lozenges. Half of the participants will also get to join online volunteer activities and a digital hub for social support. The study is looking to see if people can successfully quit smoking for at least 7 days, confirmed by a test, 26 weeks after their quit date. You can join if you are between 18 and 100 years old, identify as a sexual and/or gender minority, and are not currently using other smoking cessation treatments or have serious psychological distress. The current status of this study is unclear.
- Study design
- This is an interventional study with 400 planned participants. It is a randomized controlled trial, meaning participants are randomly assigned to one of two groups.
- What's involved
- You would receive remotely-delivered smoking cessation support and 12 weeks of mailed Nicotine Replacement Therapy. Some participants will also engage in online volunteer activities and a digital hub. All activities are conducted remotely.
- Compensation
- Not stated in the trial record.
- Follow-up
- You will be followed for 26 weeks after your quit date to check for smoking abstinence.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Empowering Cessation ACS South Region
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Julia McQuoid, PhD · PRINCIPAL_INVESTIGATOR · University of Oklahoma
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Exclusion
What this trial measures
- Biochemically-verified 7-day Point Prevalence Abstinence (PPA) at 26 weeks26 weeks post-quit-date
Self-reported smoking cessation abstinence will be biochemically verified with the iCOQuit Smokerlyzer expired carbon monoxide device 26 weeks after the participant's quit smoking date.